Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Provectus Biopharmaceuticals Inc (NYSE MKT LLC:PVCT)

0.4175
Delayed Data
As of 3:26pm ET
 +0.013 / +3.21%
Today’s Change
0.32
Today|||52-Week Range
1.20
-47.81%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2011

2012

2013

2014
Revenue and IncomeNet Revenues0.000.000.000.00--
Depreciation And Amortization678.5K677.3K677.5K679.7K
 
 
 
 
 
 
Operating ExpensesGross Income-678.5K-677.3K-677.5K-679.7K
 
 
 
 
 
General Expenses20.8M13.7M12.4M16.1M
 
 
 
 
 
Research And Development8.8M5.0M3.6M5.1M
 
 
 
 
 
Total Operating Expenses21.4M14.3M13.0M16.8M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-21.4M-14.3M-13.0M-16.8M
 
 
 
 
 
Extraordinary Credit2.0M1.8M0.006.6M
 
 
 
 
Extraordinary Charge0.000.00-14.7M0.00
 
 
Other Expenses1.5K0.000.000.00
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-19.4M-12.6M-27.7M-10.2M
 
 
 
 
 
Preferred Dividend-247.0K-183.2K-1.2M0.00
 
 
 
 
Net Income-19.4M-12.6M-27.7M-10.2M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS105.7M113.0M132.0M175.8M
 
 
 
 
 
Shares To Calculate EPS Diluted105.7M113.0M132.0M175.8M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.19-$0.11-$0.22-$0.06
 
 
 
 
 
EPS Diluted-$0.19-$0.11-$0.22-$0.06